Therapeutic composition for wound healing

2:

• The therapeutic composition of claim 1, further comprising glycerinated gelatin.

3:

• The therapeutic composition of claim 1, further comprising synthetic fatty acids of a carbon chain length of 6 carbons to 22 carbons.

4:

• The therapeutic composition of claim 1, wherein the beta-glucan is curdlan, laminaran, pachymaran, lentinan, pleuran, schizophyllan, sclerotinan, sclero-beta-glucan, grifolan, yeast beta-glucan, or barley beta-glucan.

5:

• The therapeutic composition of claim 1, further comprising a triglyceride, wherein the triglyceride comprises at least one fatty acid selected from the group consisting of arachidic acid, linoleic acid, linolenic acid, myristic acid, oleic acid, palmitic acid, palmitoleic acid, and stearic acid.

6:

• The therapeutic composition of claim 1, wherein the beta-glucan is derived from Euglena gracilis, bacteria, a mushroom fungus, a yeast, and/or at least one cereal source selected from the group consisting of oat, barley, wheat, and rye.

7:

• The therapeutic composition of claim 1, wherein the beta-glucan is synthetically prepared.

8:

• The therapeutic composition of claim 1, wherein the beta-glucan is a linear polymer and/or a branched polymer.

9:

• The therapeutic composition of claim 1, wherein the at least one secondary polysaccharide is selected from the group consisting of arabinogalactan, fucoidan, pectin, and galactomannan.

10:

• The therapeutic composition of claim 1, wherein the beta-glucan is sulfonated, phosphorylated, aminated, and/or nitrated.

11:

• The therapeutic composition of claim 1, wherein the rate of wound healing increases by at least 1.25 times to 25 times relative to the rate of wound healing without the therapeutic composition.

12:

• The therapeutic composition of claim 1, wherein the beta-glucan comprises about 0.1% to about 50% by weight, relative to the total weight of the therapeutic composition.

13:

• The therapeutic composition of claim 1, wherein the fatty acid comprises about 0.1% to about 45% by weight, relative to the total weight of the therapeutic composition.

14:

• The therapeutic composition of claim 1, wherein the secondary polysaccharide comprises about 0.1% to about 20% by weight, relative to the total weight of the therapeutic composition.

15:

• The therapeutic composition of claim 1, wherein the therapeutic composition is in a form of a tablet, capsule, suspension, cream, ointment, lotion, powder, gel, solution, paste, spray, foam, oil, enema, suppository, a slow release matrix.

17:

• The method of claim 16, further comprising glycerinated gelatin, and/or synthetic fatty acids, comprising a carbon chain length of 6 carbons to 22 carbons, and/or a triglyceride, comprising at least one fatty acids selected from the group consisting of arachidic acid, linoleic acid, linolenic acid, myristic acid, oleic acid, palmitic acid, palmitoleic acid, and stearic acid.

18:

• The method of claim 16, wherein the therapeutic composition is administered in a cavity of the subject.

19:

• The method of claim 16, wherein the therapeutic composition is administered in a form of a capsule, a suspension, a cream, an ointment, a lotion, a powder, gel, a solution, a paste, a spray, a foam, an oil, an enema, a suppository, or a slow release matrix.

20:

• The method of claim 16, wherein the wound is an anal fissure or a vaginal tear.